ArticleOncology letters2026
Prognostic value of the preoperative lactate dehydrogenase-to-albumin ratio in patients with gastrointestinal cancer.
Article in Oncology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastrointestinal cancer (GIC) remains a major clinical burden, and readily available biomarkers are needed to improve preoperative prognostic assessment and risk stratification. The present study aimed to evaluate the prognostic significance of the preoperative lactate dehydrogenase-to-albumin ratio (LAR) in patients with GIC. A comprehensive search was performed in PubMed, Embase and the Cochrane Library to identify relevant studies published from the date of database inception to March 20, 2025. The extracted outcomes included hazard ratios (HRs) for overall survival (OS) and recurrence-free survival (RFS) and odds ratios (ORs) for major postoperative complications. A total of five independent studies involving 6,379 patients were included in the present meta-analysis. A higher preoperative LAR was significantly associated with poorer OS [HR=1.90; 95% confidence interval (CI), 1.63-2.21; P<0.001]. Subgroup analysis confirmed the robustness of this association across analytical models, cancer types, countries and LAR cut-off values. A higher LAR was also associated with poorer RFS (HR=1.83; 95% CI, 1.52-2.20; P<0.001) and a higher risk of major postoperative complications (OR=2.36; 95% CI, 1.49-3.74; P<0.001). In conclusion, preoperative LAR may serve as a useful prognostic biomarker for survival outcomes in patients with GIC. Incorporating this readily available and low-cost biomarker into routine preoperative assessment may help improve perioperative risk stratification and guide postoperative management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.